Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Option Care Health Inc Market Cap
The Option Care Health Inc (OPCH) share price is expected to increase by 35.09% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered OPCH. Price targets range from $36 at the low end to $43 at the high end. The current analyst consensus for OPCH is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
Option Care Health Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Option Care Health Inc will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of OPCH.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Constantine Davides JMP Securities | Market Outperform | $37 | Maintains | Sep 30, 2024 |
| Michael Petusky Barrington Research | Outperform | $40 | Maintains | Aug 1, 2024 |
| Michael Petusky Barrington Research | Outperform | $38 | Maintains | Jul 25, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $36 | Initiates | Jul 16, 2024 |
| Michael Petusky Barrington Research | Outperform | $38 | Maintains | Apr 24, 2024 |
| Brian Tanquilut Jefferies | Buy | $38 | Maintains | Mar 4, 2024 |
| Michael Petusky Barrington Research | Outperform | $38 | Maintains | Feb 23, 2024 |
| Michael Petusky Barrington Research | Outperform | $35 | Maintains | Oct 26, 2023 |
| Lisa Gill JP Morgan | Overweight | $44 | Maintains | Oct 18, 2023 |
| Michael Petusky Barrington Research | Outperform | $41 | Maintains | Jul 28, 2023 |
| David Macdonald Truist Securities | Buy | $39 | Reiterates | Jun 27, 2023 |
| Michael Petusky Barrington Research | Outperform | $34 | Maintains | May 5, 2023 |
| Pito Chickering Deutsche Bank | Buy | $32.5 | Maintains | May 5, 2023 |
| Brian Tanquilut Jefferies | Buy | $38 | Reinstates | Feb 27, 2023 |
| Michael Petusky Barrington Research | Outperform | $38 | Maintains | Oct 28, 2022 |
| Jamie Perse Goldman Sachs | Buy | $40 | Maintains | Aug 22, 2022 |
| Michael Petusky Barrington Research | Outperform | $37 | Maintains | Jul 28, 2022 |
Canaccord Genuity | Buy | $24 | Maintains | Aug 4, 2021 |
| Jamie Perse Goldman Sachs | Buy | $25 | Upgrade | Jul 19, 2021 |
| Richard Close Canaccord Genuity | Buy | $24 | Maintains | Mar 12, 2021 |
When did it IPO
1996
Staff Count
5,809
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. John C. Rademacher
Market Cap
$4.99B
In 2023, OPCH generated $4.30B in revenue, which was a increase of 9.06% from the previous year. This can be seen as a signal that OPCH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 31 Jul 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Option Care Health, Inc. will hold its Q2 2024 Earnings Conference Call on July 31, 2024, at 8:30 AM ET, featuring executives including CEO John Rademacher and CFO Mike Shapiro.
Why It Matters - The earnings conference call provides insights into Option Care Health's financial performance and strategic direction, influencing stock valuations and investor sentiment.
Wed, 31 Jul 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Option Care Health, Inc. (Nasdaq: OPCH) reported its financial results for Q2 2024, ending June 30. Further details on performance were not provided in the excerpt.
Why It Matters - Option Care Health's Q2 financial results indicate performance trends that can influence stock valuation and investor sentiment, impacting future investment decisions.
Wed, 31 Jul 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Option Care (OPCH) reported Q3 earnings of $0.30 per share, surpassing the Zacks Consensus Estimate of $0.28, but down from $0.63 per share a year earlier.
Why It Matters - Option Care's earnings beat expectations, indicating stronger performance than anticipated, but the decline from last year's earnings may raise concerns about growth sustainability.
Thu, 01 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Zacks uses its Rank system, focusing on earnings estimates and revisions, to identify strong stocks, while also monitoring value, growth, and momentum trends.
Why It Matters - The emphasis on earnings estimates and revisions highlights potential stock performance, guiding investors toward strong picks in value, growth, and momentum trends.
Thu, 01 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Wall Street analysts project a 31.8% upside for Option Care (OPCH), supported by positive earnings estimate revisions.
Why It Matters - The 31.8% upside in price targets suggests strong growth potential for Option Care (OPCH), bolstered by positive earnings revisions, indicating possible future stock appreciation.
Thu, 01 Aug 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - Investors are comparing Option Care (OPCH) and Astrana Health, Inc. (ASTH) for potential value in the Medical - Outpatient and Home Healthcare sector.
Why It Matters - The comparison between Option Care and Astrana Health highlights potential investment opportunities, influencing stock selection and portfolio strategy in the outpatient and home healthcare sector.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
